Abstract
Neuroinflammation plays an important role in the pathophysiology of Alzheimer’s disease. The cannabinoid type 2 receptor (CB2R) is an emerging target for neuroinflammation and therapeutics of Alzheimer’s disease. Here, we aim to assess the alterations in brain CB2R levels and evaluate novel CB2R imaging tracers in the arcAß mouse model of Alzheimer’s disease amyloidosis. Immunohistochemical staining for amyloid-ß deposits (6E10), microgliosis (anti-Iba1 and anti-CD68 antibodies), astrocytes (GFAP) and the anti-CB2R antibody was performed on brain slices from 17-month-old arcAß mice. Autoradiography using the CB2R imaging probes [18F]RoSMA-18-d6, [11C]RSR-056, and [11C]RS-028 and mRNA analysis were performed in brain tissue from arcAß and non-transgenic littermate (NTL) mice at 6, 17, and 24 months of age. Specific increased CB2R immunofluorescence intensities on the increased number of GFAP-positive astrocytes and Iba1-positive microglia were detected in the hippocampus and cortex of 17-month-old arcAß mice compared to NTL mice. CB2R immunofluorescence was higher in glial cells inside 6E10-positive amyloid-ß deposits than peri-plaque glial cells, which showed low background immunofluorescence in the hippocampus and cortex of 17-month-old arcAß mice. Ex vivo autoradiography showed that the specific binding of [18F]RoSMA-18-d6 and [11C]RSR-056 was comparable in arcAß and NTL mice at 6, 17, and 24 months of age. The level of Cnr2 mRNA expression in the brain was not significantly different between arcAß and NTL mice at 6, 17, or 24 months of age. In conclusion, we demonstrated pronounced specific increases in microglial and astroglial CB2R expression levels in a mouse model of AD-related cerebral amyloidosis, emphasizing CB2R as a suitable target for imaging neuroinflammation.
Keywords: Alzheimer’s disease; astrocyte; autoradiography; cannabinoid type 2 receptor (CB2R); microglia; neuroinflammation; positron emission tomography.
Copyright © 2022 Kecheliev, Spinelli, Herde, Haider, Mu, Klohs, Ametamey and Ni.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
In vivo Imaging of Cannabinoid Type 2 Receptors: Functional and Structural Alterations in Mouse Model of Cerebral Ischemia by PET and MRI.Mol Imaging Biol. 2022 Oct;24(5):700-709. doi: 10.1007/s11307-021-01655-4. Epub 2021 Oct 12.PMID: 34642898 Free PMC article.
-
Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer’s disease.J Neuroinflammation. 2018 May 24;15(1):158. doi: 10.1186/s12974-018-1174-9.PMID: 29793509 Free PMC article.
-
Abstracts of Presentations at the Association of Clinical Scientists 143rd Meeting Louisville, KY May 11-14,2022.Ann Clin Lab Sci. 2022 May;52(3):511-525.PMID: 35777803
-
Positron emission tomography of type 2 cannabinoid receptors for detecting inflammation in the central nervous system.Acta Pharmacol Sin. 2019 Mar;40(3):351-357. doi: 10.1038/s41401-018-0035-5. Epub 2018 Jun 19.PMID: 29921889 Free PMC article. Review.
-
Positron Emission Tomography in Animal Models of Alzheimer’s Disease Amyloidosis: Translational Implications.Pharmaceuticals (Basel). 2021 Nov 18;14(11):1179. doi: 10.3390/ph14111179.PMID: 34832961 Free PMC article. Review.
References
-
- Caillé F., Cacheux F., Peyronneau M. A., Jego B., Jaumain E., Pottier G., et al. (2017). From Structure-Activity relationships on thiazole derivatives to the in vivo evaluation of a new radiotracer for cannabinoid subtype 2 PET imaging. Mol. Pharm. 14 4064–4078. 10.1021/acs.molpharmaceut.7b00746 – DOI – PubMed
LinkOut – more resources
-
Full Text Sources
-
Miscellaneous